- ►shouxi.net X Ge, JD Piganelli, HM Tse, S Bertera, CE … - Diabetes, 2006 - Am Diabetes Assoc This study addressed an important biological question, namely how certain HLA
molecules modulate the disease risk conferred by other HLA molecules. The HLA
molecules under investigation were HLA-DQ8 and -DR4, the two most prevalent ... Cited by 2 - Related articles - BL Direct - All 5 versions
M Trucco, N Giannoukakis - Gene Therapy, 2005 - journals2005.pasteur.ac.ir Page 1. Gene Therapy Volume 12, Issue 7 (April 2005) Type 1 diabetes: MHC tailored
for diabetes cell therapy M Trucco and N Giannoukakis ... Cited by 8 - Related articles - All 4 versions
[CITATION] TGF-beta and CD41CD251 regulatory T cells
D Elias, A Avron, M Tamir, I Raz - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2006 - interscience.wiley.com Abstract: DiaPep277 is an immunomodulatory peptide that arrests β cell
destruction in mouse models of type 1 diabetes mellitus (T1DM). This article
extends an original pilot observation to two studies of 61 patients (age > ... Cited by 4 - Related articles - BL Direct - All 4 versions
[CITATION] Dendritic cells with TGF-beta1 differentiate naive CD41CD25-T cells into islet-protective …
X Luo, KV Tarbell, H Yang, K Pothoven, SL … - Proc Natl Acad Sci USA, 2007 Cited by 3 - Related articles
N Giannoukakis - IDrugs: the investigational drugs journal, 2002 - ncbi.nlm.nih.gov Neurocrine is developing NBI-6024 in collaboration with Taisho, as part of
Neurocrine's altered peptide ligand (APL) program, as a potential treatment for
type I diabetes. By July 2002, Neurocrine had completed four phase I/II ... Cited by 3 - Related articles - All 3 versions
E Liu, L Yu, H Moriyama, GS Eisenbarth - Methods in molecular medicine, 2004 - Springer Summary Animal models have contributed enormously to study in the field of type
1 diabetes. Per- haps the most intensively studied model is the nonobese
diabetic (NOD) mouse, which devel- ops an autoimmune-mediated spontaneous ... Cited by 3 - Related articles - BL Direct - All 3 versions
F Dotta, E Anastasi, C Tiberti, U Di Mario - Journal of endocrinological investigation - ncbi.nlm.nih.gov 1: J Endocrinol Invest. 1994 Jul-Aug;17(7):497-508. Autoantigens in type 1 diabetes
mellitus. Dotta F, Anastasi E, Tiberti C, Di Mario U. ... Cited by 3 - Related articles - BL Direct - All 2 versions
WA Rudert, M Trucco - Pediatr Diabetes, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 2 versions
AA Kallan, RR de Vries, BO Roep - Apmis, 1996 - interscience.wiley.com Autoimmune T cells reactive to β-cell autoantigens are generally believed to
play an essential role in the immune-mediated selective pancreatic islet β-cell
destruction process leading to insulin-dependent diabetes mellitus (IDDM). ... Cited by 4 - Related articles - All 3 versions
